Adamed Group
VC Fund
Czosnow, Poland
Adamed Group is a VC fund in Czosnow focused on Health Care and B2B. In 2010, Adamed Group was founded, consisting of: Adamed, Pabianickie Zakłady Farmaceutyczne Polfa and Adamed Consumer Healthcare among others.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries Adamed Group invests in
Stages Adamed Group invests in
Countries Adamed Group invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
1 more contact available
Round size
- Series A
- $6.6M–$10M
Investment Focus
Industry
- Health Care 2 (40%)
- B2B 1 (20%)
- Medical 1 (20%)
- Chemical 1 (20%)
- Software 1 (20%)
Stage
- Series A 2 (40%)
- Seed 1 (20%)
- Pre-Seed 1 (20%)
- Venture - Series Unknown 1 (20%)
Country
- Poland 2 (40%)
- Germany 1 (20%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Joanna Matanowska
RA Team Leader
|
RA Team Leader | Total investments: 0 | Find email | |
Justyna Kwiatkowska
In-Licensing Manager
|
In-Licensing Manager | Total investments: 0 | Find email | |
Marcin Szczecinski
Investment Manager
|
Investment Manager | Total investments: 1 | Find email | |
Marian Adamkiewicz
Founder
|
Founder | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Inuru
|
We democratize lighting by making a OLED technology affordable. Despite it's paper-thin design and recyclability, OLED has failed to see a larger market adaptation outside of displays, due to high production costs. Inuru hast set it's sails to change that. We use printing technology to manufacture lighting on demand, reducingmanufacturing cost by up to 95%. This allows to bring light and displays into places it has not been before. We deliver it in the form of low cost OLED labels to customers like CATTIER, COCA COLA and DISPLATE and soon will launch product in the field of Clothing and Medical Applications. We own a fully automated OLED manufacturing line Germany. | $10M / Series A / Oct 18, 2023 | |
Apeiron Synthesis
|
Apeiron Synthesis develops catalysts, with a broad application in pharmaceuticals, flavors, and fragrances and the production of polymers and rubber. They develop a broad portfolio of patented and patent-pending catalysts that can satisfy nearly any process using metathesis which is used to deliver process-specific catalysts and also to providevalue to its clients across the whole research and development, implementation, and production process. | $4.8M / Seed / Dec 21, 2022 | |
|
Apeiron Synthesis
|
Apeiron Synthesis develops catalysts, with a broad application in pharmaceuticals, flavors, and fragrances and the production of polymers and rubber. They develop a broad portfolio of patented and patent-pending catalysts that can satisfy nearly any process using metathesis which is used to deliver process-specific catalysts and also to providevalue to its clients across the whole research and development, implementation, and production process. | $4.8M / Venture - Series Unknown / Dec 21, 2022 | |
goodsleeper
|
Digital therapeutics for insomnia. | $279.6K / Pre-Seed / May 26, 2022 | |
Telemedi
|
Since 2014, we’ve been upskilling and providing businesses with a plug&play digital healthcare platform including modules like telemedicine, automated triage, Artificial Intelligence, medical devices monitoring and API integrations. We are trusted partner in advanced digital healthcare solutions. | $6.6M / Series A / Feb 01, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Adamed Group invest in?
Adamed Group invests primarily in Health Care, B2B and Medical startups, most often at Series A and Seed stage. Most of the 5 investments tracked by Shizune back companies in Poland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Adamed Group's check size?
Adamed Group typically joins rounds of $6.6M–$10M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Adamed Group participates in.
How do I contact Adamed Group?
Public channels for Adamed Group include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Adamed Group?
The team at Adamed Group includes Joanna Matanowska (RA Team Leader), Justyna Kwiatkowska (In-Licensing Manager) and Marcin Szczecinski (Investment Manager). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
